Your browser doesn't support javascript.
loading
Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA Sequencing.
Yang, Yunpeng; Huang, Jie; Wang, Tao; Zhou, Jianya; Zheng, Jing; Feng, Jifeng; Zhuang, Wu; Chen, Jianhua; Zhao, Jun; Zhong, Wei; Zhao, Yanqiu; Zhang, Yiping; Song, Yong; Hu, Yi; Yu, Zhuang; Gong, Youling; Chen, Yuan; Ye, Feng; Zhang, Shucai; Cao, Lejie; Fan, Yun; Wu, Gang; Guo, Yubiao; Zhou, Chengzhi; Ma, Kewei; Fang, Jian; Feng, Weineng; Liu, Yunpeng; Zheng, Zhendong; Li, Gaofeng; Wang, Huijie; Cang, Shundong; Wu, Ning; Song, Wei; Liu, Xiaoqing; Zhao, Shijun; Ding, Lieming; Mao, Li; Selvaggi, Giovanni; Zhu, Larry; Xiao, Shanshan; Yuan, Xiaobin; Shen, Zhilin; Zhang, Li.
Afiliação
  • Yang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Huang J; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Wang T; Hangzhou Repugene Technology, Hangzhou, People's Republic of China.
  • Zhou J; Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China. Electronic address: zhoujy@zju.edu.cn.
  • Zheng J; Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  • Feng J; Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
  • Zhuang W; Department of Thoracic Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, People's Republic of China.
  • Chen J; Department of Medical Oncology-Chest, Hunan Cancer Hospital, Changsha, People's Republic of China.
  • Zhao J; Department of Thoracic Oncology, Beijing Cancer Hospital, Beijing, People's Republic of China.
  • Zhong W; Department of Pulmonary Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China.
  • Zhao Y; Respiratory Department of Internal Medicine, Henan Provincial Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
  • Zhang Y; Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
  • Song Y; Division of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, People's Republic of China.
  • Hu Y; Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Yu Z; Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
  • Gong Y; Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Chen Y; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Ye F; Department of Medical Oncology, Cancer Hospital, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, People's Republic of China.
  • Zhang S; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, People's Republic of China.
  • Cao L; Respiratory Medicine, The First Affiliated Hospital of the University of Science and Technology of China, Anhui Provincial Hospital, Hefei, People's Republic of China.
  • Fan Y; Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
  • Wu G; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Guo Y; Pulmonary & Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Zhou C; Respiratory Medicine Department, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
  • Ma K; Cancer Center, The First Hospital of Jilin University, Changchun, People's Republic of China.
  • Fang J; Department of Thoracic Oncology, Beijing Cancer Hospital, Beijing, People's Republic of China.
  • Feng W; Department of Head and Neck and Thoracic Medical Oncology, The First People's Hospital of Foshan, Foshan, People's Republic of China.
  • Liu Y; Oncology Medicine, The First Hospital of China Medical University, Shenyang, People's Republic of China.
  • Zheng Z; Oncology Department, General Hospital of Northern Theater Command, Shenyang, People's Republic of China.
  • Li G; 2nd Department of Thoracic Surgery, Yunnan Cancer Hospital, Kunming, People's Republic of China.
  • Wang H; Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Cang S; Medical Oncology, Henan Provincial People's Hospital, Henan, People's Republic of China.
  • Wu N; PET-CT Center & Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China.
  • Song W; Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China.
  • Liu X; Department of Pulmonary Oncology, The Fifth Medical Centre Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Zhao S; Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China.
  • Ding L; Betta Pharmaceuticals Co., Ltd., Hangzhou, People's Republic of China.
  • Mao L; Betta Pharmaceuticals Co., Ltd., Hangzhou, People's Republic of China.
  • Selvaggi G; X-covery Holdings, Palm Beach Gardens, Florida.
  • Zhu L; Betta Pharmaceuticals Co., Ltd., Hangzhou, People's Republic of China.
  • Xiao S; Hangzhou Repugene Technology, Hangzhou, People's Republic of China.
  • Yuan X; Betta Pharmaceuticals Co., Ltd., Hangzhou, People's Republic of China.
  • Shen Z; Betta Pharmaceuticals Co., Ltd., Hangzhou, People's Republic of China.
  • Zhang L; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China. Electronic address: zhangli@sysucc.org.cn.
J Thorac Oncol ; 16(5): 827-839, 2021 05.
Article em En | MEDLINE | ID: mdl-33588113
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Tumoral Circulante / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Tumoral Circulante / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos